Discover
DYN
Dyne Therapeutics, Inc.
17.11
2 x 12.86
2 x 21.76
bid
ask
-
0.95
5.26%
2 @ 04:00 PM
17.06 -0.05 (0.29%)
| Ytd | -12.53% | |
| 1y | 22.92% |
16.96
day range
18.14
11.92
52 week range
27.30
| Open | 18.07 | Prev Close | 18.06 | Low | 16.96 | High | 18.14 | Mkt Cap | 3.20B |
| Vol | 4.85M | Avg Vol | 2.67M | EPS | -3.26 | P/E | N/A | Forward P/E | -5.13 |
| Beta | 1.08 | Short Ratio | 11.68 | Inst. Own | 103.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 23.98 | 200-d Avg | 19.80 | 1yr Est | 37.20 |
| Income Statement | |||
| Operating Expenses | 181.66M | ||
| Research and Development Expense | 152.17M | ||
| Selling, General and Administrative Expense | 29.49M | ||
| Operating Income | -181.66M | ||
| Interest Expense | 4.60M | ||
| Net Income | -178.56M | ||
| Net Income Common Stock | -178.56M | ||
| Net Income Common Stock (USD) | -178.56M | ||
| Consolidated Income | -178.56M | ||
| Earnings per Basic Share | -1.08 | ||
| Earnings per Basic Share (USD) | -1.08 | ||
| Earnings per Diluted Share | -1.08 | ||
| Earning Before Interest & Taxes (EBIT) | -173.96M | ||
| Earning Before Interest & Taxes (USD) | -173.96M | ||
| Weighted Average Shares | 165.45M | ||
| Weighted Average Shares Diluted | 165.45M | ||
| Balance Sheet | |||
| Cash and Equivalents | 676.11M | ||
| Cash and Equivalents (USD) | 676.11M | ||
| Investments | 222.36M | ||
| Investments Current | 222.36M | ||
| Current Assets | 937.89M | ||
| Property, Plant & Equipment Net | 44.82M | ||
| Total Assets | 994.01M | ||
| Debt Current | 19.52M | ||
| Total Debt | 233.35M | ||
| Current Liabilities | 78.03M | ||
| Debt Non-Current | 213.83M | ||
| Total Liabilities | 291.86M | ||
| Accumulated Retained Earnings (Deficit) | -1.70B | ||
| Accumulated Other Comprehensive Income | -353.00K | ||
| Shareholders Equity | 702.15M | ||
| Shareholders Equity (USD) | 702.15M | ||
| Assets Non-Current | 56.12M | ||
| Total Debt (USD) | 233.35M | ||
| Liabilities Non-Current | 213.83M | ||
| Trade and Non-Trade Payables | 12.15M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 650.00K | ||
| Net Cash Flow from Financing | 58.11M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -76.97M | ||
| Capital Expenditure | -1.51M | ||
| Issuance (Purchase) of Equity Shares | 737.00K | ||
| Issuance (Repayment) of Debt Securities | 57.37M | ||
| Net Cash Flow from Investing | -4.79M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -3.28M | ||
| Net Cash Flow from Operations | -130.29M | ||
| Share Based Compensation | 14.98M | ||